Skip to main content

CORRECTION article

Front. Pharmacol., 02 June 2022
Sec. Neuropharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.929835
This article is part of the Research Topic Advances in Neuroprotective Agents for Cerebral Ischemia Treatment View all 24 articles

Corrigendum: Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway

This article is a correction to:

  1. Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway

    1. Read original article
Ke Liu&#x;Ke Liu1†Lulu Li&#x;Lulu Li2†Zhijun Liu&#x;Zhijun Liu1†Gang LiGang Li1Yanqing WuYanqing Wu1Xingjun JiangXingjun Jiang1Mengdie WangMengdie Wang1Yanmin ChangYanmin Chang1Tingting JiangTingting Jiang1Jianheng LuoJianheng Luo1Jiahui ZhuJiahui Zhu1Hongge Li Hongge Li1*Yong Wang Yong Wang1*
  • 1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 2Department of Neurology, People’s Hospital of Zhengzhou, People’s Hospital of Henan University of Chinese Medicine, Zhengzhou, China

A Corrigendum on
Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway

by Liu K, Li L, Liu Z, Li G, Wu Y, Jiang X, Wang M, Chang Y, Jiang T, Luo J, Zhu J, Li H and Wang Y (2022). Front. Pharmacol. 13:832611. doi: 10.3389/fphar.2022.832611

In the published article, there was an error in Affiliation 1. Instead of “Department of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China,” it should be “Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cerebral ischemia-reperfusion injury, metformin, AMP-activated protein kinase, neuronal apoptosis, brain-derived neurotrophic factor

Citation: Liu K, Li L, Liu Z, Li G, Wu Y, Jiang X, Wang M, Chang Y, Jiang T, Luo J, Zhu J, Li H and Wang Y (2022) Corrigendum: Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway. Front. Pharmacol. 13:929835. doi: 10.3389/fphar.2022.929835

Received: 27 April 2022; Accepted: 29 April 2022;
Published: 02 June 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Liu, Li, Liu, Li, Wu, Jiang, Wang, Chang, Jiang, Luo, Zhu, Li and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hongge Li, hgeli0609@163.com; Yong Wang, 370687495@qq.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.